a public good project by the
Synthesis
Company
of California

© 2026

Anca Milea | doi.page

0 works0 citations0 h-index

Anca Milea

University Health Network(CA)Princess Margaret Cancer Centre(CA)Trillium Therapeutics (Canada)(CA)

Publications by Year

Research Areas

Ovarian cancer diagnosis and treatment, BRCA gene mutations in cancer, Reproductive Biology and Fertility, Genetic factors in colorectal cancer, Phagocytosis and Immune Regulation

Most-Cited Works

→ Phase I Study of the CD47 Blocker TTI-621 in Patients with Relapsed or Refractory Hematologic Malignancies(2021)187 cited
→ A distinct innate lymphoid cell population regulates tumor-associated T cells(2017)139 cited
→ Low malignant potential tumors with micropapillary features are molecularly similar to low-grade serous carcinoma of the ovary(2010)69 cited
→ Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma(2013)54 cited
→ Proliferation in the Normal FTE Is a Hallmark of the Follicular Phase, Not BRCA Mutation Status(2012)40 cited
→ Loss of LKB1 and p53 synergizes to alter fallopian tube epithelial phenotype and high-grade serous tumorigenesis(2015)39 cited

→ Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers(2011)

37 cited

→ Integrative Transcriptome Analyses of the Human Fallopian Tube: Fimbria and Ampulla—Site of Origin of Serous Carcinoma of the Ovary(2020)27 cited

→ CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma(2019)15 cited

→ Abstract PR03: Molecular profiling of advanced solid tumors at Princess Margaret Cancer Centre and patient outcomes with genotype-matched clinical trials(2016)6 cited